GlassScriptPhysician profile
Taemin Oh
NPI 1336529924
$7,605.82
in general payments reported to CMS, 2019-2025
9 companies · $2,687 in 2025
The $2,687 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $521 · 2023: $63.42 · 2024: $4,170 · 2025: $2,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,765 · Consulting Fee: $1,950 · Travel and Lodging: $1,288 · Education: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,765.34 |
| Consulting Fee | $1,950.00 |
| Travel and Lodging | $1,288.43 |
| Education | $916.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $4,342.36 | 2024-2025 | The Tether |
| Alphatec Spine, INC | $1,186.28 | 2024-2025 | Other - Miscellaneous, Invictus Open |
| Globus Medical, INC. | $757.62 | 2022-2024 | Creo Threaded, Reline, Magec Spinal Bracing and Distraction System |
| Stryker Corporation | $343.43 | 2023-2024 | N/A, Monterey Al, Bio Dbm |
| Medtronic, INC. | $322.41 | 2021-2022 | |
| Arteriocyte Medical Systems, INC. | $302.32 | 2024 | Magellan |
| Si-Bone, INC. | $173.47 | 2025 | |
| Cerapedics INC. | $98.75 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Biomarin Pharmaceutical INC. | $79.18 | 2025 | Brineura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taemin Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.